ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
SANA holding history
Sana Biotechnology, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SANA overviewAll 13F holders of SANAFull Q2 2026 holdings
- Shares (Q2 2026)
- 33,172
- Value
- $115.8K
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 33,172 | $115.8K | <0.1% | −3,084−8.5% | Reduced | Holders |
| Q1 2026 | 36,256 | $104.4K | <0.1% | −5,870−13.9% | Reduced | Holders |
| Q4 2025 | 42,126 | $171.5K | <0.1% | +10,096+31.5% | Added | Holders |
| Q3 2025 | 32,030 | $113.7K | <0.1% | −3,752−10.5% | Reduced | Holders |
| Q2 2025 | 35,782 | $97.7K | <0.1% | −2,908−7.5% | Reduced | Holders |
| Q1 2025 | 38,690 | $65.0K | <0.1% | −9,118−19.1% | Reduced | Holders |
| Q4 2024 | 47,808 | $77.9K | <0.1% | +9,679+25.4% | Added | Holders |
| Q3 2024 | 38,129 | $158.6K | <0.1% | +11,603+43.7% | Added | Holders |
| Q2 2024 | 26,526 | $144.8K | <0.1% | −6,164−18.9% | Reduced | Holders |
| Q1 2024 | 32,690 | $326.9K | <0.1% | +4,210+14.8% | Added | Holders |
| Q4 2023 | 28,480 | $116.2K | <0.1% | +3,490+14.0% | Added | Holders |
| Q3 2023 | 24,990 | $96.7K | <0.1% | +471+1.9% | Added | Holders |
| Q2 2023 | 24,519 | $146.1K | <0.1% | +820+3.5% | Added | Holders |
| Q1 2023 | 23,699 | $77.5K | <0.1% | −3,513−12.9% | Reduced | Holders |
| Q4 2022 | 27,212 | $107.5K | <0.1% | +1,397+5.4% | Added | Holders |
| Q3 2022 | 25,815 | $155.0K | <0.1% | +1,045+4.2% | Added | Holders |
| Q2 2022 | 24,770 | $160.0K | <0.1% | −10,943−30.6% | Reduced | Holders |
| Q1 2022 | 35,713 | $295.0K | <0.1% | −9,743−21.4% | Reduced | Holders |
| Q4 2021 | 45,456 | $704.0K | <0.1% | +34,390+310.8% | Added | Holders |
| Q3 2021 | 11,066 | $249.0K | <0.1% | +11,066 | New | Holders |